HK1006496A1 - Therapeutic agents and autoimmune diseases. - Google Patents

Therapeutic agents and autoimmune diseases.

Info

Publication number
HK1006496A1
HK1006496A1 HK98104738A HK98104738A HK1006496A1 HK 1006496 A1 HK1006496 A1 HK 1006496A1 HK 98104738 A HK98104738 A HK 98104738A HK 98104738 A HK98104738 A HK 98104738A HK 1006496 A1 HK1006496 A1 HK 1006496A1
Authority
HK
Hong Kong
Prior art keywords
agent
therapeutic agents
autoimmune diseases
etx
ctx
Prior art date
Application number
HK98104738A
Other languages
English (en)
Inventor
Neil Andrew Williams
Timothy Raymond Hirst
Toufic Osman Nashar
Original Assignee
Univ Bristol
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Bristol filed Critical Univ Bristol
Publication of HK1006496A1 publication Critical patent/HK1006496A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK98104738A 1995-07-05 1998-06-02 Therapeutic agents and autoimmune diseases. HK1006496A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513733.7A GB9513733D0 (en) 1995-07-05 1995-07-05 Therapeutic agents
PCT/GB1996/001614 WO1997002045A1 (en) 1995-07-05 1996-07-05 Therapeutic agents and autoimmune diseases

Publications (1)

Publication Number Publication Date
HK1006496A1 true HK1006496A1 (en) 1999-03-05

Family

ID=10777189

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98104738A HK1006496A1 (en) 1995-07-05 1998-06-02 Therapeutic agents and autoimmune diseases.

Country Status (23)

Country Link
US (1) US6287563B1 (cs)
EP (1) EP0841939B1 (cs)
JP (1) JP4024298B2 (cs)
KR (1) KR100452000B1 (cs)
CN (1) CN1313150C (cs)
AT (1) ATE275968T1 (cs)
AU (1) AU724516B2 (cs)
CA (1) CA2225788C (cs)
CZ (1) CZ298670B6 (cs)
DE (1) DE69633393T2 (cs)
DK (1) DK0841939T3 (cs)
ES (1) ES2229276T3 (cs)
GB (1) GB9513733D0 (cs)
HK (1) HK1006496A1 (cs)
HU (1) HU224248B1 (cs)
MX (1) MX9800241A (cs)
NO (1) NO319747B1 (cs)
NZ (1) NZ311762A (cs)
PL (1) PL187266B1 (cs)
PT (1) PT841939E (cs)
RU (1) RU2203088C2 (cs)
SI (1) SI0841939T1 (cs)
WO (1) WO1997002045A1 (cs)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588763B2 (en) 1995-07-05 2009-09-15 Trident Pharmaceuticals, Inc. Methods for the prevention against or treatment of diabetes with ETXB and/or insulin

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB9801871D0 (en) * 1998-01-28 1998-03-25 Univ Bristol Therapies
KR20010043441A (ko) * 1998-05-08 2001-05-25 더 유니버시티 오브 브리스톨 백신용 면역조절제
EP1075274A2 (en) * 1998-05-08 2001-02-14 University Of Bristol Immunomodulators for vaccines
US7041296B1 (en) 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit
WO2001034175A2 (en) * 1999-11-12 2001-05-17 The Government Of The United States Of America, Asrepresented By The Secretary, Dept. Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin b subunit
CA2358061A1 (en) * 2000-09-08 2002-03-08 Stemcell Technologies Inc. Novel antibody compositions for the negative selection of specific rat leukocyte subsets
GB0115382D0 (en) 2001-06-22 2001-08-15 Univ Bristol Mutant
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
CN105050621B (zh) * 2013-02-14 2018-10-23 康奈尔大学 防止和治疗多发性硬化症的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5681571A (en) * 1993-10-08 1997-10-28 Duotol Ab Immunological tolerance-inducing agent

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7588763B2 (en) 1995-07-05 2009-09-15 Trident Pharmaceuticals, Inc. Methods for the prevention against or treatment of diabetes with ETXB and/or insulin

Also Published As

Publication number Publication date
KR100452000B1 (ko) 2004-11-20
CZ298670B6 (cs) 2007-12-19
MX9800241A (es) 1998-11-30
WO1997002045A1 (en) 1997-01-23
PL324424A1 (en) 1998-05-25
DE69633393D1 (de) 2004-10-21
RU2203088C2 (ru) 2003-04-27
EP0841939B1 (en) 2004-09-15
NO980005D0 (no) 1998-01-02
AU724516B2 (en) 2000-09-21
ES2229276T3 (es) 2005-04-16
HUP9900147A2 (hu) 1999-05-28
NO980005L (no) 1998-03-05
CA2225788A1 (en) 1997-01-23
EP0841939A1 (en) 1998-05-20
JPH11508586A (ja) 1999-07-27
PT841939E (pt) 2005-02-28
HUP9900147A3 (en) 1999-11-29
ATE275968T1 (de) 2004-10-15
CZ1298A3 (cs) 1998-06-17
KR19990028578A (ko) 1999-04-15
CN1313150C (zh) 2007-05-02
JP4024298B2 (ja) 2007-12-19
PL187266B1 (pl) 2004-06-30
SI0841939T1 (en) 2005-04-30
CA2225788C (en) 2010-09-21
GB9513733D0 (en) 1995-09-06
NZ311762A (en) 2001-04-27
CN1192693A (zh) 1998-09-09
DK0841939T3 (da) 2005-01-24
NO319747B1 (no) 2005-09-12
HU224248B1 (hu) 2005-07-28
DE69633393T2 (de) 2005-11-10
US6287563B1 (en) 2001-09-11
AU6314296A (en) 1997-02-05

Similar Documents

Publication Publication Date Title
DK0696205T3 (da) Anvendelse af neuro-afledte fetale cellelinier til transplantationsterapi
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
HK1006496A1 (en) Therapeutic agents and autoimmune diseases.
AU1447097A (en) Anchoring device for posterior vertebral osteosynthesis
GB9317104D0 (en) Therapeutic heterocycles
PH31652A (en) Dihydrolipoic acid as ophthalmological agent to suppress intolerable reactions in the aea between implants and living body tissue.
UA32429C2 (uk) Засіб для лікування нетримання сечі
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
ZA955443B (en) Novel mutant hIL-4 proteins as antagonists or partial agonists of human interleukin 4
GR3019514T3 (en) Pharmaceutical preparation for the treatment of prolonged coagulation time
SG52537A1 (en) Methods and compositions for the treatment of cell proliferation disorders
RU98101907A (ru) Терапевтические агенты и аутоимунные заболевания
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
NZ294878A (en) Water soluble derivatives of epipodophyllotoxin and medicaments
EP0373771A3 (en) New pharmaceutical uses for cystatins
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
EP0904094A4 (en) TREATMENT OF BONE DISEASES USING ADRENOMEDULLINE
GR3001850T3 (en) Expellants of phytopathogenic microbes
EP0408525A3 (en) Use in therapy of 10-amino-5,6-dihydro-11h-dibenzo(b,e)azepine-6,11-dione and derivatives as drugs for use in the treatment of urinary incontinence
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
UA19596A (uk) Спосіб лікуваhhя гіпертоhічhої хвороби гірудорефлексотерапією
UA29707A (uk) Спосіб відновлення кісткових тканин при переломах
DE69432517T2 (de) Verfahren zur vorhersage der effektivität der behandlung von tumoren durch in-vitro bestimmung der überlebens- und vermehrungsfähigkeit
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120705